Zdrowie i gospodarka · 01/04/2002

FDA Announces Preliminary Draft Proposed Rule on Current Good Manufacturing Practice for PET Drug Products

The Food and Drug Administration (FDA) is releasing a preliminary draft proposed rule outlining current good manufacturing practice (CGMP) requirements for positron emission tomography (PET) drug products, in accordance with the Food and Drug Administration Modernization Act of 1997, and invites public discussion at an upcoming meeting.